周二早盘，美高梅中国（02282）股价表现强劲，盘中大涨6.41%，引起市场广泛关注。
消息面上，摩根大通发布研报，上调美高梅中国的目标价3.8%，从13港元提升至13.5港元，并维持"增持"评级。摩根大通分析师表示，他们提高了美高梅中国2025-2026财年的EBITDA预测3%，并确认该公司为行业首选。
值得注意的是，摩根大通认为美高梅中国的潜在回报率大于40%，这一积极展望显著提振了投资者信心。在利好消息的刺激下，美高梅中国股价强势上涨，显示出市场对该公司未来发展前景的看好。
周二早盘，美高梅中国（02282）股价表现强劲，盘中大涨6.41%，引起市场广泛关注。
消息面上，摩根大通发布研报，上调美高梅中国的目标价3.8%，从13港元提升至13.5港元，并维持"增持"评级。摩根大通分析师表示，他们提高了美高梅中国2025-2026财年的EBITDA预测3%，并确认该公司为行业首选。
值得注意的是，摩根大通认为美高梅中国的潜在回报率大于40%，这一积极展望显著提振了投资者信心。在利好消息的刺激下，美高梅中国股价强势上涨，显示出市场对该公司未来发展前景的看好。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.